Transgenic animal for alzheimer's disease.

摘要

This invention relates in general to an animal model that is useful for developing therapeutic drugs of a disease. More in detail, the present invention relates to the creation of transgenic animals having an exogenous gene construct coding a part of beta -amyloid precursor protein (hereinafter called APP) in their genome. The exogenous gene construct is designed to overexpress in various types of the cells. <IMAGE>